Mednet Logo
CommunityHospital Medicine

What is your approach for using anticoagulation/aspirin in patients with multiple myeloma?

2 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Washington, Fred Hutchinson Cancer Research Center
Answered on

Excellent question with lots of nuances but no clear answer. I'll start with my gestalt approach, which is to consider a DOAC for every patient with myeloma if all of the following are true:

  1. They are receiving an IMiD (lenalidomide or pomalidomide)
  2. They set off my 'spidey sense' with one or more of ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Chicago
Answered on

@Dr. First Last has done a wonderful job here.

My practice is to start a prophylactic dose DOAC (apixaban 2.5 mg BID, rivaroxaban 10 mg daily) for essentially all patients with newly diagnosed myeloma. This is in part because we frequently employ quadruplets and/or cafilzomib-based regimens. I tran...

Join for free or sign in to see the full answer